LEPU BIO-B Maintains 1.80 Billion Issued Shares in May 2026; Public Float Remains Compliant

Bulletin Express06-01

Lepu Biopharma Co., Ltd. (LEPU BIO-B) reported no changes to its share capital structure for the month ended 31 May 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Limited on 1 June 2026.

Key highlights:

• Authorised and issued share capital stable: The company’s authorised and issued ordinary H shares stood unchanged at 1.80 billion, each with a par value of RMB 1. Corresponding registered share capital remained at RMB 1.80 billion.

• Zero treasury shares: LEPU BIO-B held no treasury shares during the period.

• No new equity instruments: The firm reported no movements in share options, warrants, convertible securities, or other equity-linked instruments.

• Public float compliance: The company confirmed adherence to the Main Board’s minimum 25% public float requirement as at 31 May 2026.

• Governance confirmation: All statutory and regulatory obligations related to any securities issuance—and the absence thereof—were affirmed by Joint Company Secretary Ms. Li Yunyi.

With capital structure steady and regulatory compliance affirmed, LEPU BIO-B enters June 2026 with 1.80 billion issued H shares fully in public circulation and no outstanding dilutive instruments.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187497096?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-01 18:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187497096","market":"hk","top_or_hot":-1,"title":"LEPU BIO-B Maintains 1.80 Billion Issued Shares in May 2026; Public Float Remains Compliant","media":"Bulletin Express","content":"<p>Lepu Biopharma Co., Ltd. (LEPU BIO-B) reported no changes to its share capital structure for the month ended 31 May 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Limited on 1 June 2026.</p>\n\n<p>Key highlights:</p>\n<p>• Authorised and issued share capital stable: The company’s authorised and issued ordinary H shares stood unchanged at 1.80 billion, each with a par value of RMB 1. Corresponding registered share capital remained at RMB 1.80 billion.</p>\n<p>• Zero treasury shares: LEPU BIO-B held no treasury shares during the period.</p>\n<p>• No new equity instruments: The firm reported no movements in share options, warrants, convertible securities, or other equity-linked instruments.</p>\n<p>• Public float compliance: The company confirmed adherence to the Main Board’s minimum 25% public float requirement as at 31 May 2026.</p>\n<p>• Governance confirmation: All statutory and regulatory obligations related to any securities issuance—and the absence thereof—were affirmed by Joint Company Secretary Ms. Li Yunyi.</p>\n\n<p>With capital structure steady and regulatory compliance affirmed, LEPU BIO-B enters June 2026 with 1.80 billion issued H shares fully in public circulation and no outstanding dilutive instruments.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEPU BIO-B Maintains 1.80 Billion Issued Shares in May 2026; Public Float Remains Compliant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEPU BIO-B Maintains 1.80 Billion Issued Shares in May 2026; Public Float Remains Compliant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-01 18:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lepu Biopharma Co., Ltd. (LEPU BIO-B) reported no changes to its share capital structure for the month ended 31 May 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Limited on 1 June 2026.</p>\n\n<p>Key highlights:</p>\n<p>• Authorised and issued share capital stable: The company’s authorised and issued ordinary H shares stood unchanged at 1.80 billion, each with a par value of RMB 1. Corresponding registered share capital remained at RMB 1.80 billion.</p>\n<p>• Zero treasury shares: LEPU BIO-B held no treasury shares during the period.</p>\n<p>• No new equity instruments: The firm reported no movements in share options, warrants, convertible securities, or other equity-linked instruments.</p>\n<p>• Public float compliance: The company confirmed adherence to the Main Board’s minimum 25% public float requirement as at 31 May 2026.</p>\n<p>• Governance confirmation: All statutory and regulatory obligations related to any securities issuance—and the absence thereof—were affirmed by Joint Company Secretary Ms. Li Yunyi.</p>\n\n<p>With capital structure steady and regulatory compliance affirmed, LEPU BIO-B enters June 2026 with 1.80 billion issued H shares fully in public circulation and no outstanding dilutive instruments.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02157","symbol_name":"乐普生物-B","start_time":0,"source_url":"","article_id":"1187497096","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187497096","pubTimestamp":1780308370,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Lepu Biopharma Co., Ltd. (LEPU BIO-B) reported no changes to its share capital structure for the month ended 31 May 2026, according to the company’s monthly return filed with Hong Kong Exchanges and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02157":"乐普生物-B"},"translate_title":"乐普生物-B维持2026年5月18.0亿股已发行股份；公众持股量保持合规","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02157":1},"content_text":"Lepu Biopharma Co., Ltd. (LEPU BIO-B) reported no changes to its share capital structure for the month ended 31 May 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Limited on 1 June 2026.\nKey highlights:\n• Authorised and issued share capital stable: The company’s authorised and issued ordinary H shares stood unchanged at 1.80 billion, each with a par value of RMB 1. Corresponding registered share capital remained at RMB 1.80 billion.\n• Zero treasury shares: LEPU BIO-B held no treasury shares during the period.\n• No new equity instruments: The firm reported no movements in share options, warrants, convertible securities, or other equity-linked instruments.\n• Public float compliance: The company confirmed adherence to the Main Board’s minimum 25% public float requirement as at 31 May 2026.\n• Governance confirmation: All statutory and regulatory obligations related to any securities issuance—and the absence thereof—were affirmed by Joint Company Secretary Ms. Li Yunyi.\nWith capital structure steady and regulatory compliance affirmed, LEPU BIO-B enters June 2026 with 1.80 billion issued H shares fully in public circulation and no outstanding dilutive instruments.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187497096","isCrawlerRequest":true}